Radiological evidence of inflammation related to CAA is relatively common and most cases may go undetected and untreated, a Cleveland Clinic study shows.Read More
Targeting the dentate nucleus with deep brain stimulation was safe and feasible for promoting post-stroke rehabilitation in a first-in-human study. Enrollment in a controlled phase II trial is underway.
Door-to-needle times for intravenous thrombolytic therapy matter even for ischemic stroke patients who later undergo thrombectomy, a large cohort study finds.
A newly published case series bolsters support for the off-label use of flow-diverting stents in this rare condition.
Retrospective studies provide mixed results on a direct-to-angiography approach for select mobile stroke unit patients and positive findings on mechanical thrombectomy beyond the 24-hour window.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A pre/post study finds that a structured transition-of-care program can cut 30-day hospital readmissions for stroke patients roughly in half. An architect of the program shares advice for others.
Multidisciplinary researchers are charting new territory in the understanding of how cerebral autoregulation is impaired in patients with advanced liver failure.
A study of a novel virtual clinic for patients discharged from the neuro ICU shows that these patients receive frequent pharmacotherapy adjustments. The findings highlight opportunities to optimize outcomes and curb adverse events in a high-risk population.
Recent data indicate a plateauing of progress in reducing racial disparities in cerebrovascular deaths in the U.S. Initiatives like our Minority Stroke Program are designed to jump-start such progress.
Rates of cerebrovascular injury from acute respiratory distress syndrome may not be elevated in the setting of COVID-19 infection, but the latter may be associated with a unique pathophysiology deserving further research.
Cleveland Clinic just implemented an enterprise-wide change in its preferred thrombolytic for acute stroke. We share the rationale and logistics behind the change and what we hope to learn about tenecteplase moving forward.